Becker's Hospital Review

ECG Adds STAMP, a Software Platform to Drive Customer Loyalty for Health Plans

Boston, MA—October 22, 2025: ECG Management Consultants, a leading consulting firm to health systems and payers, today announced the addition of STAMP, a SaaS-based platform that enables payers to ...
Business Wire

AccurKardia Delivers Its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions

NEW YORK--(BUSINESS WIRE)--AccurKardia, an ECG-led diagnostics software company, today announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership ...
Medical Device and Diagnostic Industry (MD+DI)

AliveCor’s Tumultuous Week

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with AliveCor, after the U.S. Court of Appeals ruled in favor of Apple, ...
FierceBiotech

AccurKardia's automated ECG analysis software snags FDA nod

With cases of arrhythmia and heart disease on the rise—thanks in large part to an aging global population—more tools and technologies are needed to speed up the process of diagnosing and beginning ...
Becker's Hospital Review

ECG software analytics company joins Innovators’ Network at American Heart Association

Electrocardiogram software analytics company AccurKardia is joining the Innovators’ Network at the American Heart Association Center for Health and Technology Innovation. The Innovator’s Network is a ...

AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets

TORONTO, ON / ACCESS Newswire / January 20, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), is ...
Yahoo Finance

HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) ...
Business Wire

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) ...
Hosted on MSN

FDA clears HeartBeam’s at-home arrhythmia assessment tool

HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for deployment in patients’ ...
Seeking Alpha

CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias

GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada Toronto, Ontario--(Newsfile Corp. - September 30, 2024) - ...
Nasdaq

CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias

GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada The GEMS Rhythm arrhythmia and morphology abnormality AI ...